4063 — Shin-Etsu Chemical Co Balance Sheet
0.000.00%
- ¥9tn
- ¥8tn
- ¥3tn
- 79
- 41
- 62
- 69
Annual balance sheet for Shin-Etsu Chemical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,152,921 | 1,436,080 | 1,600,648 | 1,719,709 | 1,811,678 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 337,868 | 467,695 | 466,862 | 474,763 | 504,761 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,914,909 | 2,437,975 | 2,863,524 | 3,036,509 | 3,209,652 |
| Net Property, Plant And Equipment | 1,165,149 | 1,290,165 | 1,518,190 | 1,746,577 | 2,065,945 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,380,615 | 4,053,412 | 4,730,394 | 5,147,974 | 5,636,601 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 363,246 | 477,759 | 507,810 | 520,395 | 537,094 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 565,463 | 724,114 | 856,184 | 885,209 | 974,128 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 2,815,152 | 3,329,298 | 3,874,210 | 4,262,765 | 4,662,473 |
| Total Liabilities & Shareholders' Equity | 3,380,615 | 4,053,412 | 4,730,394 | 5,147,974 | 5,636,601 |
| Total Common Shares Outstanding |